Unipharm
Tel Aviv, Israel· Est.
Israeli generic pharma leader offering fast, flexible production and out‑licensing of niche oral dosage forms worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Israeli generic pharma leader offering fast, flexible production and out‑licensing of niche oral dosage forms worldwide.
CardiovascularCentral Nervous SystemAnti‑InfectivesMen’s HealthMusculoskeletalGastrointestinalOphthalmic
Technology Platform
EU‑GMP certified oral solid and solution formulation platform with rapid development, scalable manufacturing, and full regulatory dossier support.
Opportunities
Expansion of out‑licensing agreements for niche generics and leveraging EU‑GMP capacity to enter emerging markets.
Risk Factors
Pricing pressure in generic markets, regulatory hurdles, and competition from larger multinational generic manufacturers.
Competitive Landscape
Competes with other generic firms but differentiates through niche product focus, rapid flexible production, and strong IP litigation track record.